On the other hand, results of a systematic review with meta-analysis of the results of 30 RCTs involving 7,567 patients demonstrated that the adamantane analog, memantine ( Figure 1 ) was effective for the improvement of cognitive function in patients with AD compared to placebo, a finding that was highly significant either with or without the addition of cholinesterase inhibitors ( Kishi et al., 2017 ).
← all excerpts
Adamantanes for the treatment of neurodegenerative diseases in the presence of SARS-CoV-2.
1
—
—